Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Pharmacology

• Publication date

  1999-08-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-2999(99)00471-9PMID 10493104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate.

  1998cited by this paper
• N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.

  1996cited by this paper
• Inhibition of advanced protein glycation by 8-quinolinecarboxylic hydrazide.

  1996cited by this paper
• Selective inhibition of inducible nitric oxide synthase by aminoguanidine.

  1996cited by this paper
• Prevention of myocardial infarction by vitamin B6.

  1995cited by this paper
• Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL.

  1995cited by this paper
• Effects of aminoguanidine and pyridoxal phosphate on glycation reaction of aspartate aminotransferase and serum albumin.

  1995cited by this paper
• Selective inhibition of the inducible nitric oxide synthase by aminoguanidine.

  1993cited by this paper
• Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.

  1992cited by this paper
• Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

  1992cited by this paper
• A microassay for protein glycation based on the periodate method.

  1991cited by this paper
• A deficiency of vitamin B6 is a plausible molecular basis of the retinopathy of patients with diabetes mellitus.

  1991cited by this paper
• Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure.

  1991cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation.

  1988cited by this paper
• Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.

  1986cited by this paper
• Biochemical evidence for a deficiency of vitamin B6 in the carpal tunnel syndrome based on a crossover clinical study.

  1978cited by this paper

• A Novel Rhodamine Functionalized Schiff Base Type Ratiometric Fluorescent Chemosensor for the Sensing of Hg2+ Ions; Experimental and Theoretical Approach

  2025cites this paper
• The Counterion (SO42− and NO3−) Effect on Crystallographic, Quantum-Chemical, Protein-, and DNA-Binding Properties of Two Novel Copper(II)–Pyridoxal-Aminoguanidine Complexes

  2024cites this paper
• A two-step strategy to synthesis new aminoguanidinium complexes: cytotoxic effect and perspectives

  2022cites this paper
• Mechanistic physicochemical insights into glycation and drug binding by serum albumin: Implications in diabetic conditions.

  2021cites this paper
• A Domino Reaction for the Synthesis of Novel 1,3-Dihydrofuro[3,4-c]pyridines from Pyridoxal and Ketones

  2020cites this paper
• Synthesis and reactivity of an osmium(iii) aminoguanidine complex.

  2019cites this paper
• Pyridoxylidene aminoguanidine and its copper(II) complexes – Syntheses, structure and DFT calculations

  2017cites this paper
• Ameliorating Effects of Green Synthesized Silver Nanoparticles on Glycated End Product Induced Reactive Oxygen Species Production and Cellular Toxicity in Osteogenic Saos-2 Cells.

  2016cites this paper
• Crystal structure of bis{4-bromo-2-[(carbamimidamidoimino)methyl]phenolato-κ3 N,N′,O}cobalt(III) nitrate dimethylformamide monosolvate

  2016cites this paper
• Syntheses and characterization of 2-acetylpyridine-aminoguanidine and its copper(II) complexes: Crystallographic and antimicrobial study

  2016cites this paper
• Antiglycation therapy: Discovery of promising antiglycation agents for the management of diabetic complications

  2016cites this paper
• Effect of Scavenging Circulating Reactive Carbonyls by Oral Pyridoxamine in Uremic Rats on Peritoneal Dialysis

  2016cites this paper
• β-Resorcylidene aminoguanidine (RAG) dilates coronary arteries in an endothelium-independent manner

  2015cites this paper
• Synthesis and X-ray structural characterization of square-pyramidal copper(II) complex with aminoguanidine derivative

  2015cites this paper
• Synthesis, structure and photoluminescence of (PLAGH)2[ZnCl4] and comparative analysis of photoluminescence properties with tris(2,2′-bipyridine)ruthenium(II)

  2015cites this paper
• Synthesis, Characterization and X-ray Analysis of a Copper(II) Complex with Pyridoxal-aminoguanidine Ligand

  2014cites this paper
• Exploring the space of histidine containing dipeptides in search of novel efficient RCS sequestering agents.

  2013cites this paper
• Synthesis, structure and photoluminescence properties of copper(II) and cobalt(III) complexes with pyridoxalaminoguanidine

  2013cites this paper
• Synthesis, spectroscopic (FT-IR/NMR) characterization, X-ray structure and DFT studies on (E)-2-(1-phenylethylidene) hydrazinecarboximidamide nitrate hemimethanol.

  2013cites this paper
• Formation of Schiff bases of O-phosphorylethanolamine and O-phospho-D,L-serine with pyridoxal 5'-phosphate. experimental and theoretical studies.

  2012cites this paper
• Synthesis, characterization and crystal structure of square-pyramidal copper(II) complexes with pyridoxylidene aminoguanidine

  2012cites this paper
• Syntheses, crystal structures, and electrochemical characterizations of two octahedral iron(III) complexes with Schiff base of pyridoxal and aminoguanidine

  2012cites this paper
• SYNTHESIS AND X-RAY CRYSTAL STRUCTURE OF A COPPER(II) COMPLEX WITH PYRIDOXAL-AMINOGUANIDINE (PLAG) LIGAND

  2011cites this paper
• J SYNTHESIS AND X-RAY CRYSTAL STRUCTURE OF A COPPER ( II ) COMPLEX WITH PYRIDOXAL-AMINOGUANIDINE ( PLAG ) LIGAND

  2011cites this paper
• Substituted benzenediol Schiff bases as promising new anti-glycation agents

  2011cites this paper
• Inhibitory effect of fermentation byproducts on formation of advanced glycation end-products

  2010cites this paper
• {4-[(Carbamimidoylhydrazono)methyl-kappa2N1,N4]-5-hydroxymethyl-2-methylpyridinium-3-olate-kappaO}(methanol-kappaO)copper(II) dinitrate.

  2009cites this paper
• Synthesis of bis-Schiff bases of isatins and their antiglycation activity.

  2009cites this paper
• Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity.

  2009cites this paper
• In vitro evaluation of the cytotoxicity and genotoxicity of resorcylidene aminoguanidine in human diploid cells B-HNF-1.

  2008cites this paper
• Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls

  2007influential citation
• In vitro glycation of brain aminophospholipids by acetoacetate and its inhibition by urea.

  2007cites this paper
• Synthesis, spectroscopic and X-ray characterization of a copper(II) complex with the Schiff base derived from pyridoxal and aminoguanidine: NMR spectral studies of the ligand.

  2007cites this paper
• Effect of pyridoxylidene aminoguanidine on human diploid cells B-HEF-2: in vitro cytotoxicity test and cytogenetic analysis.

  2006cites this paper
• Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus.

  2006cites this paper
• Lipoxidation‐Derived Reactive Carbonyl Species as Potential Drug Targets in Preventing Protein Carbonylation and Related Cellular Dysfunction

  2006cites this paper
• Protection against glycation and similar post-translational modifications of proteins.

  2006cites this paper
• EFFECT OF NOS INHIBITION ON RAT GASTRIC MATRIX METALLOPROTEINASE PRODUCTION DURING ENDOTOXEMIA

  2006cites this paper
• The effect of serotonin on epinephrine modulation of transepithelial ion transport in isolated frog skin.

  2006cites this paper
• Metal complexes with Schiff-base ligands pyridoxal and semicarbazide-based derivatives

  2005cites this paper
• Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.

  2005cites this paper
• The Maillard Reaction: Chemistry, Biochemistry and Implications

  2005cites this paper
• Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats.

  2004cites this paper
• Pyridoxal-Aminoguanidine Adduct is More Effective than Aminoguanidine in Preventing Neuropathy and Cataract in Diabetic Rats

  2004cites this paper
• Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.

  2004cites this paper
• Inhibition of in vitro pyrraline formation by L-arginine and polyamines.

  2004cites this paper
• Antioxidant activity of a Schiff base of pyridoxal and aminoguanidine.

  2003cites this paper
• Cytotoxicity test and cytogenetic analysis of effects of aminoguanidine in vitro.

  2003cites this paper
• EFFECT OF SELECTED SUBSTANCES WITH ANTIGLYCATIVE AND ANTIOXIDATIVE PROPERTIES ON ERYTHROCYTE DEFORMABILITY IN DIABETIC PATIENTS

  2002cites this paper
• A glycation inhibitor, aminoguanidine and pyridoxal adduct, suppresses the development of diabetic nephropathy

  2002cites this paper
• Aminoguanidine pyridoxal adduct is superior to aminoguanidine for preventing diabetic nephropathy in mice.

  2002cites this paper